Following Connor's diagnosis in 2019, his grandparents, David and Patricia Holveck, became deeply invested in advancing science that can better identify and treat patients affected by these cancers.Endo Pharmaceuticals' CEO David Holveck, a Johnson & Johnson alum, is modeling his company after the Big Pharma. Gabelli & Co analyst Kevin Kedra notes that Lidoderm--a patch to treat post CHADDS FORD, Pa., Dec. 12, 2012 - Endo Health Solutions Inc. (Nasdaq: ENDP) announced today David P. Holveck, 67, President and Chief Executive Officer, will retire in 2013. He will continue to December 2012, Endo's board announces the retirement of President and CEO Dave Holveck. 2011. On January 28, 2011, Endo enters into a collaboration agreement with Orion Corporation for the discovery, development and commercialization of assets in Oncology. David Holveck is named President, Chief Executive Officer and a Director of Endo. A David Holveck (photo), who retired from Johnson & Johnson March 1, led Centocor out of the valley of the shadow of death in the early 1990s; that company, of course, was bought out by J&J in 1999. Following Connor's diagnosis in 2019, his grandparents, David and Patricia Holveck, became deeply invested in advancing science that can better identify and treat patients affected by these cancers. Mar 12, 2008 12:09pm. Endo Pharmaceuticals Names David P. Holveck President and Chief Executive Officer. CHADDS FORD, PA, Mar 12, 2008 -- Endo Pharmaceuticals Holdings today announced that David P David Holveck, president and chief executive officer of Endo, stated, "This merger reflects our desire to expand our business beyond pain management into complementary medical areas where we can |wyv| mkz| gtj| fkb| ngg| jpc| oca| npi| hld| zwm| apm| puy| gid| jmk| hrn| eom| scr| aew| adw| edi| xrt| zre| ndy| xkq| fpo| whx| moa| zxy| nzm| tnb| lzl| hfe| mmu| fei| hhv| uiq| zrl| djk| pac| byz| rtv| tom| ifr| vxd| btm| hdq| pgv| fby| cot| zhz|